Summary: Researchers discovered tiny deposits of elemental copper and iron inside the brains of two people who had Alzheimer’s disease. These metal particles appeared at the cores of amyloid plaques, and the observations may provide new insight into how elemental forms of metals participate in the disease process and suggest new directions for therapy and research.
Source: AAAS
Researchers have unexpectedly identified minute deposits of elemental copper (Cu0) and elemental iron (Fe0) within amyloid plaques from the brains of two deceased Alzheimer’s patients.
The discovery sheds light on a previously underexplored aspect of metal chemistry in the human brain. While copper and iron ions bound in enzymes and proteins are long known to play essential roles in brain function, this study reveals that the brain can also contain metallic, elemental forms of these metals localized in pathological structures. Because elemental metals are chemically more reactive than their oxidized counterparts, their presence inside plaques raises new questions about how they might affect neuronal health and plaque biology.
To map both the distribution and the chemical states of copper and iron within human amyloid plaque material, James Everett and colleagues analyzed plaque cores extracted from the gray matter of the frontal and temporal lobes of two individuals who had Alzheimer’s disease. The team used synchrotron-based scanning transmission x-ray microscopy (STXM), a high-resolution imaging and spectroscopy technique that can distinguish different oxidation states and provide spatially resolved chemical information.
The investigators found that a single plaque could contain iron and copper in multiple chemically reduced states, including ionized species as well as metallic elemental forms. This coexistence of different redox states inside a single plaque suggests that repeated local reduction and oxidation reactions may be occurring within these aggregates of misfolded protein. Such redox cycling could influence the reactivity and toxicity of metal-containing phases and might contribute to biochemical conditions that promote neuronal damage.
The authors emphasize that the presence of Cu0 and Fe0 in human brain tissue is unexpected. Previous observations of biogenic metallic phases had been limited to microorganisms, viruses, and plants. Detecting these elemental metals in human amyloid plaques suggests that biogenic metal mineralization processes may operate in more diverse biological contexts than previously appreciated.
“The unexpected identification of Cu0 and Fe0 within Alzheimer’s disease amyloid plaques suggests that biogenic metallic elements, previously observed only in microorganisms, viruses, and plants, can also occur in humans,” the authors write.
The study further notes that the chemical reactivity of metallic copper and iron differs substantially from the more commonly detected oxide forms of these elements in brain tissue. Elemental metals are typically more prone to participate in redox reactions, which can generate reactive species and alter local chemical environments. “The reactivity of these metallic phases differs from their metal oxide counterparts previously detected in the human brain and has the scope to redefine our understanding of metal neurochemistry and the role of metal toxicity in neurodegenerative diseases,” the researchers add.
These observations do not yet establish causality between elemental metal deposits and Alzheimer’s disease progression, but they point to new mechanistic questions that deserve follow-up. For example, future work could investigate whether elemental metal formation is a common feature across many patients and stages of disease, whether these metallic particles originate from dysregulated metal transport and handling, and how they interact with amyloid proteins and surrounding cells. Understanding these relationships may open avenues for therapeutic strategies that target metal chemistry in the brain.
Because elemental metal phases are chemically distinct from ionized or oxidized metal forms, they may require different approaches for detection, monitoring, and intervention. The use of advanced spectroscopic imaging techniques such as STXM was essential to this study because conventional imaging or bulk chemical assays might not differentiate metallic nanoparticles from other metal species. Continued development and application of high-resolution, chemically specific imaging methods will help clarify the prevalence and significance of elemental metals in neurodegenerative conditions.
About this Alzheimer’s disease research news
Source: AAAS
Contact: Press Office – AAAS
Image: The image is in the public domain
Original Research: The study will appear in Science Advances